Titan Pharmaceuticals
+$0.02 (+1.98%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.
About TTNP
Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
CEO
Sunil Bhonsle, MBA
Employees
12
Headquarters
South San Francisco, California
Founded
1992
TTNP Key Statistics
Market cap
10.21M
Price-Earnings ratio
—
Dividend yield
—
Average volume
146.48K
High today
$1.03
Low today
$0.995
Open price
$1.00
Volume
178.08K
52 Week high
$4.61
52 Week low
$0.85
TTNP Earnings
-$1.50
-$1.00
-$0.50
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 30, After Hours